<DOC>
	<DOCNO>NCT01832233</DOCNO>
	<brief_summary>People hypertension high risk cardiovascular disease death important low blood pressure normal level quickly possible . Previous research establish renal nerve denervation successfully lower blood pressure measure arm physician 's office . This study conduct investigator determine whether renal nerve denervation also help low blood pressure 24 hour , well central aortic blood pressure , pressure exert aorta closer heart may better predictor cardiovascular problem . The investigator also want know whether beneficial effect blood pressure last 2 year , whether renal denervation reduces number medication patient need take , whether reduces glucose insulin level blood since hypertension also related obesity diabetes .</brief_summary>
	<brief_title>Renal Denervation Patients With Chronic Kidney Disease</brief_title>
	<detailed_description>Study design patient : This study conduct use prospective , single-arm pre-/post-intervention design 2 year . Fifty consecutive stage 3 4 CKD patient resistant hypertension Regina Qu'Appelle Health Region ( RQHR ) multidisciplinary CKD clinic agree undergo RDN include study . Patients consider eligible &gt; 18 year age , exhibit systolic BP great 140 mm Hg despite maximal dos 3 agent ( 1 diuretic ) currently 4 BP med control SBP le 140 mm Hg . Once identify resistant hypertension base chart review , patient undergo follow assessment : 24-hour urine catecholamine , sodium cortisol ; CT renal angiogram length diameter renal artery , rule stenosis/fibromuscular dysplasia , assessment adrenal gland nodule ; measurement thyroid stimulate hormone ( TSH ) serum cortisol exclude secondary cause hypertension . If secondary cause hypertension identify , study coordinator approach patient next clinic appointment regard participation trial Patients exclude evaluation identify functional adrenal adenoma ; CT scan reveals renal artery length ( either side ) less 20 mm diameter le 4 mm ; pregnant planning pregnancy within study period ; document evidence moderate-to-severe aortic stenosis ; cardiac event necessitate introduction clopidogrel occur prior 12 month ; currently use Warfarin history CVA within 6 month prior procedure . Patients clonidine sympatholytic agent exclude study . Our institutional review ethic board ( REB-12-73 ) grant approval study . If patient fit criterion agree undergo procedure , study coordinator organize/perform follow assessment : Ambulatory blood pressure office blood pressure : Patients undergo 24-hour blood pressure monitoring ( Welch Allyn , Skaneateles Falls , NY , USA ) , follow information document : 12-hour daytime systolic pressure ( mm Hg ) , 12-hour daytime diastolic pressure ( mm Hg ) , 12-hour night-time systolic pressure ( mm Hg ) 12-hour night-time diastolic pressure ( mm Hg ) . The following day , patient 24-hour arm cuff remove , sit quiet room 10 minute study coordinator take peripheral blood pressure measurement use BP Tru ( BPM 100 , BP Tru medical device , Coquitlam , BC , Canada ) non-dominant arm , measure 6 consecutive blood pressure ( first exclude , average last 5 reading document ) . Central blood pressure : After obtain mean 5 BP reading , radial artery waveform record high-fidelity micromanometer wrist dominant arm calibrate previously measure mean 5 BP reading . Waveforms process dedicate software ( Sphygmocor CPV ( EM3 ) software version 9 ; AtCor Medical ) . The integral system software use calculate average radial artery waveform derive corresponding central aortic pressure waveform use previously validate generalize transfer function12,13 . Aortic waveform subject analysis use SphygmoCor software identify time peak/shoulder first second pressure wave component ( T1 , T2 ) systole . The pressure peak/shoulder first component identify P1 height , pressure difference point maximal pressure systole ( Δ P , augmentation ) identify reflect wave systole . The augmentation index ( AIx ) , define ratio augmentation central pulse pressure , express percentage : AIx : ( Δ P/PP ) X 100 , P pressure , PP pulse pressure . Pulse pressure amplification ( PPA ) express ratio central pulse pressure ( CPP ) brachial pulse pressure ( PPP ) : PPA=PPP/CPP . At least 2 consecutive radial pressure wave sampling record patient , mean use analysis . The collected data include augmentation index ( % ) , augmentation pressure ( mm Hg ) , central pulse pressure ( mm Hg ) , central systolic pressure ( mm Hg ) , central diastolic pressure ( mm Hg ) , pulse pressure amplification ( mm Hg ) , time reflection ( Tr ) m pulse wave velocity . Pulse wave velocity : The carotid femoral pulse wave velocity ( PWV ) measure patient every clinic visit . PWV determine immediately central blood pressure . This parameter determine simultaneous measurement arterial pressure wave carotid femoral artery pressure transducer . The surface distance suprasternal notch distal ( femoral ) record site measure , pressure wave transit time calculate divide distance distal site pressure wave transit time . The data collect single trained coordinator ( RJ ) , mean 2 PWV measurement take patient . Echocardiogram : The follow parameter document : Left ventricle volume , leave ventricle hypertrophy , leave ventricle function , leave atrial mass , E-wave velocity E-prime velocity . Demographic information : During clinic visit , record patient 's age , height , weight , waist circumference , race , gender , current medication take current medical condition ( peripheral artery disease , diabetes mellitus , coronary heart disease , cerebrovascular disease ) administer quality-of-life questionnaire ( EQ5D , short standardize instrument measure health-related quality life ) , complete prior procedure . Laboratory measure : The patient receive requisition blood take laboratory within 1 month prior renal denervation procedure measure follow parameter : serum fast glucose insulin , fast lipid panel , renal panel , electrolytes , osmolality , complete blood count 24-hour urine , sodium , protein , creatinine clearance , potassium , osmolality albumin/creatinine ratio . Procedure : During renal nerve ablation , catheter connect Medtronic radiofrequency generator insert percutaneously groin via femoral artery advance aorta renal artery . Total 4 6 discrete radiofrequency ablation last 2 minute , 8 watt less , perform , separate longitudinally rotationally within renal artery . The catheter system monitor tip temperature impedance , alter radiofrequency energy delivery response predetermine algorithm . The procedure take approximately 40 minute , complete ablation bilaterally . The patient receive intravenous opiate sublingual anxiolytic , per institutional protocol , reduce visceral pain well 3000 IU intra-arterial heparin renal artery prior ablation . Post-procedure , patient monitor ambulatory care unit 4 hour . The procedure time contrast volume document . The number successful ablation renal artery also record . All adverse event complication record study visit . Specific interventional-related safety data include bleed femoral pseudoaneurysm require intervention , renal artery dissection , myocardial infarction , stroke death . Follow-up schedule : The patient receive phone call study coordinator 7 day check his/her clinical condition . He/she encourage continue check his/her blood pressure routinely home ( 2 times/week ) inform attend physician his/her blood pressure fall 100 mm Hg systolic remain high 180/90 mm Hg.3 , 6 , 12 , 18 24 month 's post-procedure ( within ±1 month ) , study coordinator perform/request above-documented test . The patient also receive echocardiogram examine cardiac function 12 24 month ( ±2 month ) . The insulin sensitivity index calculate fast glucose insulin value follow : homeostasis model assessment-insulin resistance ( HOMA-IR ) ( FPG_FPI ) , FPG FPI fast plasma glucose fast plasma insulin , respectively . End point : The primary outcome interest change central blood pressure baseline 6 month post-RDN . The secondary outcome interest include change central blood pressure baseline 3 , 12 , 18 24 month post-RDN well change 24-hour peripheral blood pressure , pulse wave velocity , cardiac parameter , renal biochemical parameter fast insulin glucose level change number medication baseline 3 , 6 , 12 , 18 24 month post-RDN . Sample size consideration With one-sided type 1-error rate 5 % , sample 50 subject would provide 90 % power detect 10/5 mm Hg change systolic/diastolic central pressure baseline standard deviation 23/12 , would clinically significant . Statistical analysis Baseline data summarize descriptively . The primary outcome evaluate use one-sided paired sample t-test normally distribute data Mann-Whitney U test non-normally distribute data . Secondary outcome examine use repeat measure mixed model ANOVAs correction multiple comparison ( continuous outcome ) Χ2 test ( categorical outcome ) normally distribute data Friedman 's test ( continuous ) McNemar 's test ( categorical ) non-normally distribute data two-sided alpha set .05 . Multiple linear regression may use account potential covariates , age , BMI , gender , comorbidities change blood pressure , cardiac renal parameter insulin/glucose .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Glomerular filtration rate : 6015 mls/min per modify diet renal disease formula ( Stage 3 4 Chronic Kidney Disease ) Daytime systolic blood pressure ambulatory monitor ≥ 135 mm Hg take 3 antihypertensive include diuretic maximal dose OR ambulatory monitor systolic blood pressure &lt; 135 take 4 antihypertensive 18 year A minimum 20 mm length 4 mm diameter renal artery CT renal angiogram formal renal angiogram suitable renal denervation base Indications Use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>